The ovarian surface epithelium, a single layer of poorly differentiated epithelial cells, covers the surface of the ovary and is ruptured during ovulation. Little is known about the changes that occur in this layer before or during ovulation, and even less is known about the regenerative processes that occur after the surface is ruptured to release a mature oocyte. Recently, a population of mouse ovarian surface epithelial (MOSE) cells that exhibit progenitor/stem cell characteristics has been identified, though neither a genetic marker nor how these cells are regulated has been determined. We have identified a defined population of MOSE cells with progenitor cell characteristics that express the stem cell marker lymphocyte antigen 6 complex, locus A (LY6A; also known as stem cell antigen-1 [SCA-1]). By testing the effect of factors found in the follicular fluid at ovulation on proliferation, sphere formation, and LY6A expression, we have determined that the size of the LY6A-expressing (LY6A+) progenitor cell population is regulated by at least two ovulation-associated factors present in the follicular fluid: transforming growth factor beta 1 and leukemia-inhibitory factor. Our work has identified a population of LY6A+ MOSE progenitor cells on the surface of the ovary that may play a role in ovulatory wound healing.
INTRODUCTION
The ovarian surface epithelium (OSE) is a monolayer of squamous-to-cuboidal epithelial cells covering the surface of the ovary. Its only defined function in healthy ovaries is during the rupture-wound repair process associated with ovulation [1, 2] . Little is known about the changes occurring in the OSE before or during ovulation, and even less is known about the regenerative processes that occur after the surface is ruptured to release the mature oocyte. Ovulation is induced by a surge of the gonadotropic hormone, luteinizing hormone, and is associated with extensive architectural remodeling of the follicular structure, the overlying extracellular matrix, and the layer of OSE cells. This remodeling culminates in apoptotic degradation of the monolayer of OSE cells at the apex of the ovulating follicle, extrusion of the ovum, and repair of the epithelial wound. OSE cells in close contact with the apical wall of the preovulatory follicle secrete enzymes that lead to localized OSE cell apoptosis [3, 4] . It is hypothesized that the cells exfoliated from the dome of those follicles are replenished by progenitor cell replication and migration from the wound edges [3, 5] . Many studies have determined the effect of growth factors and hormones on the growth rate of OSE cells [6, 7] , but how these findings apply to ovulatory wound closure is unknown.
Like most epithelia, the OSE requires replacement throughout the lifetime of the individual. This process of tissue homeostasis is typically maintained by the presence of somatic progenitor cells [8] . Progenitor cells are defined by their ability to self-renew and differentiate along the lineages of their tissue of origin [9] . Many adult tissues contain progenitor cells for which the main function is to maintain tissue homeostasis by replacing cells damaged by injury or age. Progenitor cells have been reported in bone marrow and brain and many epithelia, including lung, cornea, epidermis, intestine, prostate, and mammary gland [8] .
Despite several reports of putative stem/progenitor cells in the ovarian epithelium that may support neo-oogenesis [10] [11] [12] [13] , only one report to date suggests the presence of stem/ progenitor cells in the ovarian epithelium in the context of ovulatory wound repair [14] . In that recent report, Szotek et al. [14] identified a population of mouse OSE (MOSE) cells that exhibits asymmetric label retention, colony formation, and enrichment by flow cytometric isolation of the side population (SP), but how these cells contribute to ovulatory wound repair was not determined. If a progenitor cell population does exist in the MOSE, no markers have been published, and the regulation and function of these progenitor cells during ovulation in the normal ovary have not been determined.
Using established stem/progenitor cell assays, we have identified a defined population of MOSE cells with progenitor cell characteristics. This population of putative progenitor cells expresses the stem cell marker lymphocyte antigen 6 complex, locus A (LY6A), also known as stem cell antigen-1 (SCA-1). This population is regulated by at least two factors found in the follicular fluid at the time of ovulation, indicating an important role for these cells in facilitating ovulatory wound repair.
MATERIALS AND METHODS

Experimental Animals
FVB/N mice (Jackson Laboratory) were the source of MOSE cells for all experiments. The mice were housed under a 12L:12D photoperiod with free access to food and water. All animal experiments described in the present study were performed according to the Guidelines for the Care and Use of Animals established by the Canadian Council on Animal Care, with protocols approved by the University of Ottawa Animal Care Committee.
Isolation and Culture of MOSE Cells
To establish primary cultures of MOSE cells, ovaries were individually dissected from randomly cycling, 6-wk-old FVB/N female mice. For each primary culture, 10-20 mice were used. The ovaries were rinsed twice with PBS (Hyclone), then incubated in 0.25% Trypsin/PBS (0.5 ml/ovary; Invitrogen) in a 15-ml Falcon tube at 378C at 5% CO 2 for 30 min to remove the MOSE layer. ''MOSE medium'' (a-Minimum Essential Medium [Hyclone] supplemented with 4% heat-inactivated 3:1 donor bovine serum:fetal bovine serum [DBS:FBS; PAA Laboratories, Inc.], 5 U/ml of penicillin and 0.005 mg/ ml of streptomycin solution [Sigma-Aldrich], 0.1 lg/ml of gentamicin [Invitrogen] , and 1 lg/ml of insulin-transferrin-sodium-selenite solution [ITSS; Roche]) was added to inactivate the trypsin, and the tube was agitated gently by hand to remove the MOSE cells from the ovaries. The supernatant containing the MOSE cells was centrifuged at 1000 rpm for 5 min, and the cells were resuspended in the appropriate medium. If freshly isolated MOSE cells were used, the cells were processed for the appropriate assay.
Superovulation (SOV) was induced by i.p. administration of 5 IU of equine chorionic gonadotropin (eCG; Calbiochem), followed by i.p. administration of 5 IU of human chorionic gonadotropin (hCG; Sigma) 46 h later [15] . To limit the contamination of MOSE cultures by blood, immune, and stromal cells exposed by the ovulatory wound, the mice were euthanized 72 h after hCG injection for MOSE cell isolation as described above.
For primary cultures, the MOSE cells were plated on tissue-culture plates (Becton-Dickinson) in MOSE medium at 378C with 5% CO 2 . After 24 h, the medium and any floating cells were removed from the culture and replaced with fresh MOSE medium. The cultures were passaged (trypsin and gentle agitation at 90% confluency) two to four times before use in experiments. When passaging was not necessary, the medium was changed by half every 4 days. All in vitro MOSE experiments were carried out at least three times using a minimum of two different isolations of MOSE cells with a passage number of less than 30.
SP Analysis
The MOSE cells were released from tissue-culture dishes at 90% confluency with trypsin and gentle agitation and then passed through a 40-lm cell strainer to achieve a single-cell suspension. They were then incubated for 10 min at 378C with or without the drug pump inhibitor verapamil (7.5 lM), and the fluorescent dye Hoechst 33342 (Invitrogen) was then added at a concentration of 5 lg/ml. The cells were incubated at 378C for 90 min, during which time the cells were gently mixed every 15 min to prevent cell clumping. After the 90-min exposure to the Hoechst dye, the cells were pelleted by centrifugation for 5 min at 300 3 g, the Hoechst dye was removed, and the cells were resuspended in cold 2% DBS:FBS in PBS. Dead cells were labeled by the addition of 2 lg/ml of propidium iodide, and cells that took up this dye were gated out of the analysis. SP cells were identified and electronically gated on their characteristic light-scatter properties and singular Hoechst 33342 red versus blue fluorescence emission pattern after excitation with 100 mW of 355-nm ultraviolet light on a MoFlo cell sorter (Beckman Coulter, Inc.). SP fluorescence emissions were directed toward a 610-nm dichroic filter, then captured simultaneously through both a 424/44-nm band-pass filter (blue) and a 575/26-nm (red) filter on a linearly amplified fluorescence scale [16] . Main population (MP) cells, which due to retention of the dye have a higher red and blue fluorescence than the SP, were gated as shown in Figure 1A .
Follicular Fluid and Cytokines
Bovine follicular fluid was collected and kindly provided as a gift from Dr. Marc-André Sirard, (Université de Laval, Québec, PQ). Bovine ovaries were collected from a commercial slaughterhouse and transported to the laboratory in a thermoflask containing a warm, 0.9% saline solution supplemented with 100 000 IU/L penicillin, 100 mg/L streptomycin, and 250 lg/L amphotericin B (Sigma-Aldrich). The follicular fluid was collected by aspiration of five individual preovulatory follicles (diameter, 12-22 mm) with an 18-gauge needle attached to a 10-ml disposable syringe. The follicular fluid was centrifuge at 1000 3 g for 5 min to remove any cellular debris and stored at À808C. Activated transforming growth factor beta 1 (TGFB1) levels were measured in the five bovine follicular fluid samples using a Quantikine Human TGFB1 ImmunoAssay (R&D Systems, Inc.) following the manufacturer's protocol. The TGFB1 concentration in the samples was 1.3-4.8 ng/ml, which falls within the range found in human follicular fluid [17] . Based on the volume of follicular fluid obtained (1-2 ml) and dilutions of follicular fluid previously reported in the literature [18] , the samples were diluted 1:10 in MOSE medium.
The cytokines used were mouse insulin-like growth factor II (IGF2; 30 ng/ ml), human TGFB1 (10 ng/ml), and mouse leukemia-inhibitory factor (LIF; 20 
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ng/mL; all from Sigma-Aldrich), which are present in human follicular fluid at the following concentrations: IGF2, 75-83.7 ng/ml [19] ; TGFB1, 1.75-5.81 ng/ml [17] ; and LIF, 0.43-2.89 ng/ml [20] . The concentration of LIF used in the present study was chosen taking into account its ability to inhibit the spontaneous differentiation of mouse embryonic stem cells [15] .
Proliferation Assays
Cells were plated at a density of 1 3 10 4 cells/ml in MOSE medium, and viable cells were counted using a Vi-CELL XR Cell Viability Analyzer (Beckman Coulter, Inc.) at the reported time points. When follicular fluid or cytokines were used in the assay, cells were allowed to adhere to the tissueculture plate for 24 h before the treatments were added.
Sphere Culture Conditions and Manipulations
To assess the ability of individual cells to form spheres in culture, MOSE cells were released from tissue-culture plates at 90% confluency with trypsin or were removed from freshly dissected ovaries as described above. The cells were then passed through a 40-lm cell strainer and suspended as single cells in a 1:1 mixture of methylcellulose (to prevent cell aggregation) and ''progenitor cell medium'' (PCM; 1:1 Dulbecco modified Eagle medium:Ham F12, with a B27 supplement; Invitrogen) at a density of 2 3 10 4 cells/ml per well of a 24-well tissue culture plate. Sphere formation and morphology were monitored weekly using a dissecting microscope, and spheres were counted with the aid of a grid placed under the culture dish. Sphere-forming efficiency was calculated as the percentage of single cells capable of sphere formation. The diameter of the spheres was determined using a microscope fitted with a micrometer. To determine the effect of factors found in the follicular fluid at the time of ovulation on the sphere parameters (number, size, and morphology), IGF2 (30 ng/ml), TGFB1 (10 ng/ml), and LIF (20 ng/ml) were added to the PCM before the addition of methylcellulose, 2 3 10 4 cells were plated at the abovementioned cell density for each factor, and the sphere parameters were assessed after 28 days in culture.
For passaging, spheres were released from methylcellulose by dilution with an equal volume of medium and then pelleted using centrifugation for 5 min at 300 3 g. After the sphere pellet was washed twice briefly with PBS, the spheres were dissociated with trypsin and gentle agitation. The dissociated spheres were then passed through a 40-lm cell strainer to achieve a single-cell suspension. These single cells were then placed back into sphere-culture conditions for new sphere formation. To serially passage the spheres, this process was repeated.
Magnetic Bead Assisted Cell Separation
The MOSE cells were released from tissue culture plates at 90% confluency by nonenzymatic dissociation (MULTICELL Cell Stripper; Wisent Bioproducts), passed through a 40-lm cell strainer, and then separated into LY6A-expressing (LY6A+) and non-LY6A-expressing (LY6AÀ) fractions or KIT-expressing (KIT+) and non-KIT-expressing (KITÀ) fractions using an anti-LY6A or an anti-KIT MicroBead kit with a MiniMAC separator and MS columns (Miltenyi Biotech) following the manufacturer's protocol. The antibodies were added to a single-cell suspension and incubated at 48C for 10 min. Excess antibody was washed away by the addition of 5 ml of wash buffer (PBS [pH 7.2], 0.5% bovine serum albumin, and 2 mM ethylenediaminetetra-acetic acid), followed by a 10-min centrifugation at 1500 rpm to remove the supernatant. The cells were resuspended in fresh wash buffer, and the magnetic beads were added. Following a 15-min incubation at 48C, the cells were washed and then resuspended in 500 ll of wash buffer and applied to an MS column in a magnetic holder. To increase the purity of the positive fraction, the eluted cells were passed through a second column.
Gene Expression Analysis
The RNA was extracted using an RNeasy Mini Kit (Qiagen) following the manufacturer's instructions. RNA was quantified, and cDNA was made by reverse transcriptase PCR (RT-PCR) from 1000 ng of RNA using the OneStep RT-PCR Kit (Qiagen). Gene expression was determined by relative quantitative PCR (Q-PCR) performed on an ABI 7500 FAST qRT-PCR machine (Applied Biosystems) using the Fast SYBR Green Master Mix (Invitrogen) following the manufacturer's instructions. The real-time thermal cycler program was 958C for 10 min, followed by 40 cycles of 958C for 10 sec and 608C for 30 sec. Primer pairs to amplify murine Ly6a
, and Ppia (F, 5 0 -AGG GTG GTG ACT TTA CAC GC-3 0 ; R, 5 0 -GAT GCC AGG ACC TGT ATG CT-3 0 ) were designed using OligoPerfect primer design software (Invitrogen). The expression level of Ppia mRNA was used as the endogenous control.
Flow Cytometry for LY6A Expression
The MOSE cells were released from tissue-culture dishes at 90% confluency using nonenzymatic dissociation (MULTICELL Cell Stripper), a single-cell suspension was achieved by passing the cells through a 40-lm cell strainer, and the cells were incubated for 30 min at 48C with an anti-LY6A antibody conjugated to the allophycocyanin fluorophore (Miltenyi Biotech). After unbound antibody was washed away by the addition of 5 ml of wash buffer and centrifugation for 5 min at 300 3 g, the percentage of cells with surface expression of LY6A was determined using a MoFlo cell sorter.
Immunohistochemistry
Histological sections were deparaffinized and rehydrated, and then hightemperature antigen retrieval was performed in sodium citrate buffer (pH 6; Antigen Unmasking Solution; Vector Laboratories) in a pressure cooker (Tender Cooker; Nordic Ware). Endogenous peroxidase activity was blocked by 3% hydrogen peroxide in methanol for 30 min. LY6A expression was visualized with a monoclonal rat anti-LY6A primary antibody and a polyclonal goat anti-rat secondary antibody (BD553333 and BD554016, respectively; both from BD Biosciences) using a signal amplification kit (TSA Biotin System; PerkinElmer), following the manufacturer's instructions. Developing was performed with diaminobenzidine (DAB) as a substrate (0.2% DAB, 0.001% H 2 O 2 ; Sigma-Aldrich). Sections were counterstained with Harris hematoxylin (Fisher Scientific) and mounted with Permount (Fisher Scientific). Images were obtained with the ScanScope CS system and ImageScope software (both from Aperio).
Statistical Analyses
Based on the number of conditions tested, a Student t-test or an ANOVA with a Tukey post-test was used to determine statistical significance (P , 0.05). Error bars indicate the SEM.
RESULTS
MOSE Contains a Verapamil-Sensitive SP
Based on a previous report in the literature that the MOSE contains an SP identified by flow cytometry [14] , SP analysis was used to enrich for potential MOSE progenitor cells. The identification of an SP is based on differential exclusion of the DNA-binding dye Hoechst 33342 [21] . Hoechst 33342 enters live cells, where it can be actively pumped out by ATP-binding cassette transporters like the multidrug-resistant protein 1 (MRD1) and the ATP-binding cassette, subfamily G, member 2 (ABCG2) [21] . It is thought that stem/progenitor cells express a large number of these pumps to protect themselves from toxins and, therefore, are able to pump out the dye faster than nonstem cells [21] . This technique is especially useful when no genetic stem/progenitor cell markers are known, and it is routinely used to enrich for stem/progenitor-like cells in both normal and cancerous tissues [14, 16, [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] . On average, we found that the MOSE cells grown in culture contained an SP that constitutes approximately 3% of the whole MOSE cell population (Fig. 1A) . Verapamil, a nonspecific drug pump inhibitor, abolished the SP phenotype, which indicated that the SP cells were correctly gated (Fig. 1B) .
A comparison of growth rates in culture was made between the SP, the MP, and the mixed MOSE cell population from which the SP and the MP were isolated, which was kept on ice while the cell sort was being performed (Fig. 1C) . On Day 7 of culture after sorting, the MOSE cells exhibited a 9-fold increase in cell number, and the MP showed a 6-fold increase OSE PROGENITOR CELLS ARE REGULATED BY OVULATION in cell number, when compared to Day 1. The SP cells did not proliferate during the initial 7 days after sorting but eventually began to proliferate after 4 wk. The difference in proliferation rate between the SP, the MP, and MOSE population suggests that the SP may be a distinct population of MOSE cells.
LY6A Surface Expression Marks MOSE Cells with Enhanced Sphere-Forming Ability
To identify potential genetic progenitor cell markers for the MOSE, Q-PCR was used to compare the mRNA expression levels of known stem/progenitor cell markers in the SP to the MP. LY6A, KIT (also known as CD117), and NANOG are critically involved in self renewal [32, 33] , and they have been used as markers of hematopoietic stem cells (LY6A and KIT) [22] , breast stem cells (LY6A) [22] , and embryonic stem cells (NANOG) [34] . Whereas the MP and SP both expressed mRNAs for the stem/progenitor cell markers, the SP expressed significantly higher levels of Ly6a and Kit mRNA (5-fold and 3-fold higher, respectively), and a trend toward higher levels of Nanog mRNA (2.5-fold higher) was found when compared to the MP (Fig. 2A) . Based on these results, further investigation focused on LY6A and KIT as potential markers of a population of MOSE cells enriched with progenitor cell characteristics.
To test whether surface expression of LY6A or KIT enriches for MOSE cells with progenitor cell characteristics, we used an established, quantifiable in vitro system for testing ''stemness.'' The capacity for sphere formation has been used to indicate the presence of cells with stem/progenitor cell characteristics in a variety of tissues [35] [36] [37] [38] [39] . To ensure that sphere formation was not an artifact of in vitro culture, we assessed the sphere-forming ability of freshly isolated MOSE cells. When 5 3 10 4 freshly isolated MOSE cells were placed directly into sphere-forming cultures, a small percentage (0.19% 6 0.11%) formed spheres. These spheres could be passaged at least three times (2 3 10 4 cells plated each time), suggesting the presence of cells with self-renewal capacity (Fig. 2B) . Whereas the mean number of spheres formed tended to decrease with passaging (passage 2, 0.53%; passage 3, 0.09%; and passage 4, 0.03%), the difference was not statistically significant. Primary spheres had an irregular shape, but after one passage, the spheres were more uniform, with tightly associated cells (Fig. 2C) .
Because enrichment of sphere-forming ability indicates an enrichment of cells with stem/progenitor cell characteristics, the sphere-forming assay was used to test the putative progenitor cell markers LY6A and KIT. Cultured MOSE cells were separated based on surface expression of LY6A or KIT into LY6A+ and LY6AÀ fractions (0.89% and 99.1%, respectively) or KIT+ and KITÀ fractions (2.3% and 97.7%, respectively) using magnetic bead assisted cell separation. The LY6A+ fraction expressed 240-fold higher levels of Ly6a mRNA compared to the LY6AÀ fraction, and the KIT+ fraction expressed 125-fold higher levels of Kit mRNA compared to the KITÀ fraction. The fractions were resuspended as single cells (2.4 3 10 5 cells from each fraction were plated) and tested for sphere formation in methylcellulose. Spheres were quantified after 28 days. LY6A+ cells formed 18-fold more spheres compared to all other fractions (Fig. 2D) . The sphere-generating efficiencies of the KIT+ and KITÀ MOSE fractions were not statistically different. Taken together,
FIG. 2. Putative progenitor cells in MOSE cultures.
A) The SP expresses significantly higher levels of Ly6a and Kit mRNA when compared to the MP. A trend is observed toward higher levels of Nanog mRNA. Relative transcript levels were determined by Q-PCR. *P , 0.05 compared to MP. B) Freshly isolated MOSE cells form spheres when placed in sphere-forming culture conditions. The spheres were dissociated and replated three times and evaluated for efficiency of sphere formation, as indicated by the percentage of plated cells that formed spheres. C) Morphology of spheres changes with passage. Primary spheres have an irregular shape, whereas secondary spheres are spherical and compact. Original magnification 3400. D) MOSE cells were sorted for LY6A and KIT expression, and the percentages of cells that formed spheres were determined. Error bars indicate the SEM. *P , 0.05 compared to LY6AÀ.
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these results indicated that the LY6A+ fraction is enriched for cells with stem/progenitor cell characteristics.
LY6A+ MOSE Cells Are Present as Rare Cells on the Ovarian Surface In Vivo
To visualize LY6A+ MOSE cells on the surface of the ovary in vivo, immunohistochemistry (IHC) for LY6A expression was performed on ovaries excised from 6-wk-old, normally cycling mice. Occasional LY6A+ cells were found within the MOSE layer, with an average of less than one LY6A+ cell per section (Fig. 3A) . LY6A+ MOSE cells did not appear to be associated with any particular underlying structure (i.e., follicle or corpus luteum) and tended to be more cuboidal (Fig. 3A) relative to the rest of the surface, which was covered by squamous (LY6AÀ) epithelial cells (Fig. 3B) . The oocytes of primordial follicles also appeared to stain for LY6A expression (Fig. 3A) .
SOV In Vivo Increases the Proliferation Rate of MOSE In Vitro
To examine the effects of ovulation on the OSE, MOSE cells were isolated 72 h after hCG injection from SOV mice (SOV MOSE) and, at the same time, from mice that were cycling normally. Once the primary cultures were established (each primary culture was passaged twice), the proliferation rate of the SOV MOSE was compared to the control MOSE (Fig. 4A) . SOV MOSE had a significantly faster proliferation rate at Day 11 than the control MOSE (doubling time: SOV MOSE, 4.3 days; control MOSE, 6.5 days).
To determine if exposure to the SOV hormones caused the difference in proliferation rate, cultured MOSE cells were treated in vitro with eCG and hCG in the same sequence as used for the SOV in vivo. The hormones did not alter the proliferation rate of the MOSE (Fig. 4B) , nor did treatment with a range of concentrations of estradiol (data not shown), indicating that other aspects of SOV, like the follicular fluid, may be responsible for the longer-term effects on the proliferation rate.
Follicular Fluid Increases Ly6A mRNA Expression in MOSE
Because follicular fluid is expelled and bathes the MOSE surrounding the ovulatory wound, we next studied the effect of follicular fluid on MOSE proliferation. We were unable to collect sufficient murine follicular fluid, so MOSE cells were cultured with bovine follicular fluid collected from the preovulatory follicles of heifers. Each of the five follicular fluid samples was diluted 1:10 in MOSE medium and tested independently. After 7 days, the cells were counted to assess proliferation, and RNA was extracted for Q-PCR analysis. Whereas treatment with 10% follicular fluid did not alter the growth rate of MOSE (Fig. 4C) , it did significantly increase the expression of Ly6a mRNA by 50% (Fig. 4D) . indicating that follicular fluid expelled during ovulation may regulate the size of the LY6A+ MOSE cell population or alter the expression level in those cells that already express LY6A.
Ovulation-Associated Factors Regulate the LY6A+ MOSE Fraction
As a follicle grows, several proteins accumulate in the follicular fluid, including IGF2, TGFB1, and LIF [17, 19, 20, 40, 41] . The effect of each of these factors on MOSE proliferation was determined after 7 days in adherent MOSE cell cultures. LIF increased proliferation by 1.8-fold during that period compared to control, whereas IGF2 had no effect and TGFB1 significantly decreased MOSE proliferation 2-fold (Fig. 5A) .
To determine the effect of IGF2, TGFB1, and LIF on sphere formation, MOSE cells were plated in sphere-forming conditions with each factor added to the culture medium. For each factor, 2 3 10 4 MOSE cells were plated. The number of spheres was counted and compared to untreated controls. Despite opposing effects on cell proliferation, both TGFB1 and LIF significantly increased the number of spheres formed (by 6.4-fold and 3.6-fold, respectively) (Fig. 5B) . LIF also stimulated the formation of significantly larger, more compact spheres when compared to untreated controls (average diameter, 75.6 and 58.5 lm, respectively), whereas the addition of TGFB1 caused significantly smaller (average diameter, 45.5 lm), more loosely associated spheres (Fig. 5, C and D) . Spheres that formed in the presence of IGF2 did not differ significantly in number, size, or morphology when compared to the controls.
Because the LY6A+ MOSE fraction is enriched for sphereforming cells, we investigated the effect of LIF and TGFB1 on LY6A expression. Interestingly, even though LIF caused an increase in the number of spheres formed, exposure to LIF for 1 wk in culture significantly decreased Ly6a mRNA expression 2.5-fold (Fig. 5E ). In comparison, TGFB1 increased Ly6a mRNA expression 6-fold (Fig. 5F ) and almost tripled the percentage of LY6A+ MOSE cells, as determined by flow cytometry (Fig. 5G) . These data suggest that TGFB1 may act to increase the number of spheres formed by expanding the LY6A+ MOSE fraction. 
OSE PROGENITOR CELLS ARE REGULATED BY OVULATION
To investigate this further, the effect of TGFB1 and LIF on the proliferation of LY6AÀ and LY6A+ MOSE cells was tested by placing both unsorted MOSE cells that were passed through the cell sorter without being gated and sorted LY6AÀ and LY6A+ MOSE cells into adherent cultures and exposing them to TGFB1 or LIF. After 7 days, TGFB1 significantly reduced proliferation in all cell populations, whereas LIF increased proliferation compared to controls (Fig. 5H) . Because TGFB1 did not increase the proliferation of the LY6A+ MOSE cells, this suggested that TGFB1 may expand the LY6A+ MOSE fraction by causing LY6AÀ MOSE cells to express LY6A. To test this directly, LY6AÀ MOSE cells were cultured in MOSE medium and treated with TGFB1 or LIF for 7 days, then reassessed by flow cytometry to determine the percentage of cells that express LY6A. Six percent of TGFB1-treated LY6AÀ cells expressed LY6A after 7 days of culture, whereas the percentage of control (untreated) or LIF-treated cells that expressed LY6A did not significantly differ from zero as determined by a one-sample t-test (Fig. 5I) .
DISCUSSION
We have isolated a subpopulation of MOSE cells based on the verapamil-sensitive efflux of Hoechst dye and have reported, to our knowledge for the first time, that this subpopulation shows enhanced expression of LY6A, a stem cell maker. LY6A+ MOSE cells can be detected on the surface of the mouse ovary in vivo. When compared to LY6AÀ MOSE cells, LY6A+ MOSE cells have enhanced sphere-forming efficiency (an indication of self-renewal and differentiation). These characteristics suggest that this cell population is enriched for progenitor cell activity. The behavior of these putative MOSE progenitor cells is regulated by at least two factors found in follicular fluid, TGFB1 and LIF, indicating that they may play a role in ovulatory wound healing.
Given the limited evidence for distinct subpopulations of cells in the OSE, we initiated the present study using methodologies that have been effective in isolating stem/ progenitor cells from other adult tissues. Initial experiments have shown that the MOSE contains a verapamil-sensitive SP, a phenotypic marker that has been used to identify many somatic and cancer stem cells [14, 16, [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] . The ability to efflux substances is thought to be protective against a variety of chemicals, allowing somatic stem cells to survive long term in the body [42] . The size of the SP we report is in keeping with the only other report of a MOSE SP [14] . The SP cells proliferate at a slower rate, which is also consistent with the finding by Szotek et al. [14] that label-retaining cells, which proliferate slowly, are enriched in the SP. The difference in 
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proliferation rate between the MP and MOSE cells is likely because the MOSE cells were not passed through the cell sorter and were more robust than the MP when placed into culture.
Although previous studies have identified a putative stem cell population in the OSE that may be involved in neooogenesis [10] [11] [12] [13] , no indication regarding what role these cells may play in ovulation has been reported. Similarly, Szotek et al. [14] reported the presence of label-retaining cells juxtaposed to sites of ovulation, but their importance to ovulation or ovulatory wound repair was not investigated. In the present study, we have attempted to isolate and characterize these cells to enable an examination of their role in ovulation. Herein, we have shown that a small subpopulation of MOSE cells expresses the genetic marker, LY6A, known as SCA-1 in the stem cell field. LY6A is the most commonly used genetic marker for enrichment for murine hematopoietic stem cells [43, 44] , and it has been used to prospectively isolate murine progenitor or stem cells from such diverse tissues as vascular endothelium, bone, mammary gland, prostate, skeletal muscle, heart, dermis, liver, and lung (for review, see [45] ). Whereas studies with transgenic mouse lines using the LY6A promotor to drive lacZ, green fluorescent protein (GFP), or enhanced GFP (eGFP) expression have shown that it is expressed in many tissues [46] [47] [48] [49] , the present study is to our knowledge the first report of LY6A expression in the ovary, perhaps because the single cells seen on the surface of the ovary by IHC are easily missed when screening organs for X-gal staining or GFP or eGFP expression, or because the ovaries were not closely examined in the other studies. In addition to the MOSE, LY6A staining was seen in the oocytes of primordial follicles. LY6A expression has not been previously reported in oocytes, and this observation raises the intriguing possibility of a connection between this progenitor population and neo-oogenesis, as proposed previously [10] [11] [12] [13] .
The LY6A+ MOSE cells have a higher sphere-forming efficiency than LY6AÀ MOSE cells, suggesting that LY6A surface expression marks a population of cells with progenitor cell characteristics. The sphere-forming assay tests the two fundamental properties of progenitor cells: the ability to selfrenew and the ability to differentiate. When spheres are formed from a single-cell suspension in methylcellulose, which prevents aggregation, all cells in the sphere originate from that single cell. By definition, progenitor cells are able to produce the differentiated progeny that make up the cell types within the sphere, so the number of spheres formed reflects the number of progenitor cells in the culture. Sphere formation was first used to isolate neural progenitor cells [35, 36] ; it has since been used to isolate mammary gland progenitor cells [37] [38] [39] . The fact that not every LY6A+ MOSE cell forms spheres indicates that there may be other, as-yet-undiscovered progenitor cell markers that would more efficiently enrich for MOSE cells with progenitor cell characteristics.
The MOSE cells, when taken directly off the surface of the ovary and placed into sphere culture conditions, have the ability to form spheres that can be passaged at least three times. The ability to passage spheres suggests that the cells are undergoing asymmetric division, because within the mixed ball of cells, there remains at least one cell with the ability to produce spheres. If all the cells within a sphere could produce secondary spheres, a dramatic increase in sphere-forming efficiency would be expected; however, this was not seen.
The MOSE requires repeated, localized replacement during the reproductive life span of the ovary. It remains unclear how the MOSE regenerates in response to ovulatory wounding, but at least two processes are possible: 1) Every cell in the MOSE has the same capacity to proliferate to close the wound, or 2) a small population of cells are stimulated to divide and produce differentiated daughter cells in response to some aspect of ovulation. Our results, and the work of others in rodents and nonhuman primates [5, 14, 50, 51] , support the second process, and we propose that a small population of progenitor cells participates in wound repair following ovulation.
We have shown that SOV, which causes a supraphysiological number of ovulation sites, causes a lasting increase in the proliferative capacity of the MOSE. This is consistent with the long-standing hypothesis that ovulation has a mitogenic effect on the OSE and is therefore a risk factor for ovarian cancer [52] . The gonadotropins responsible for SOV, estrogen, and 10% follicular fluid failed to directly increase MOSE proliferation in vitro. Determining what is responsible for the increase in proliferation in primary cultures from SOV ovaries may provide information about the etiology of ovarian cancer.
Both LIF and TGFB1, the levels of which are increased in follicular fluid in response to ovulation-inducing gonadotropins [17, 20, 40, 41] , increased the proportion of cells that form spheres, but their mechanisms of action differ. In addition to promoting sphere formation, LIF increased proliferation of the total population of MOSE cells and also increased proliferation of sorted LY6AÀ and LY6A+ MOSE cells. This effect on proliferation explains why LIF, in addition to producing more spheres, also produced larger spheres. It also explains the reduced Ly6a mRNA expression compared to controls, because LIF expanded the LY6A+ sphere-forming population but also expanded the LY6AÀ MOSE cell population. This suggests the intriguing possibility that this growth factor is able to promote both the expansion of the MOSE progenitor cell population as well as the proliferation of their progeny during ovulatory wound repair. The decrease in Ly6a mRNA caused by LIF treatment may be a reflection of LY6A+ MOSE cells being diluted by the proliferative effects of LIF on the LY6AÀ cells, because the majority of cells in a mixed MOSE population do not express LY6A. Additionally, LIF may be acting to expand a population of sphere-forming MOSE cells that express a still undiscovered progenitor cell marker.
The TGFB1 decreased proliferation of mixed MOSE cells, LY6AÀ MOSE cells, and LY6A+ MOSE cells; resulted in the production of smaller spheres; and increased both Ly6a mRNA and the proportion of MOSE cells expressing LY6A compared to control. It also induced LY6A surface expression in LY6AÀ MOSE cells, something that LIF was not able to do. This indicates that TGFB1 increases both the number of spheres formed and the number of LY6A+ cells by inducing LY6A expression in MOSE cells that previously did not express the marker.
Given the opposing effects of LIF and TGFB1 on both proliferation and expression of LY6A in MOSE, it was not surprising that the application of a 1:10 dilution of bovine follicular fluid, containing both of these factors (and others), did not alter the proliferation of MOSE in vitro. A determination of the relative concentration of these and other factors in murine follicular fluid and an improved understanding of the time course of the response to these factors may improve our understanding of their putative roles in the modulation of MOSE during ovulatory wound repair.
Finally, TGFB1 is a prototypic inducer of the epithelial-tomesenchymal transition (EMT), a process by which epithelial cells adopt a mesenchymal phenotype. The EMT plays an important role during development and wound healing [53] ; in fact, in response to ovulation, OSE cells surrounding the ovulatory wound adopt a mesenchymal phenotype [1] . Recently, TGFB1 and the EMT have been associated with the conversion of mammary epithelial cells into mammary stem GAMWELL ET AL. cells [54, 55] , and the maintenance of naturally occurring mammary stem cells requires the expression of transcription factors that are upregulated as a result of an EMT [54] . Our results suggest that a similar process may be occurring in the OSE, and this process is the focus of current studies.
In conclusion, the MOSE contains an LY6A+ population of cells that has enhanced progenitor cell characteristics (increased sphere-forming efficiency). This population is regulated by two factors found in follicular fluid, TGFB1 and LIF. Our findings that TGFB1 can convert LY6AÀ MOSE cells into LY6A+ progenitor cells and that LIF can induce the expansion of LY6A+ MOSE progenitor cells while also stimulating proliferation of LY6AÀ MOSE cells provide a new perspective on how LY6A expression and ovulatory wound healing may be regulated.
